8 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has declined 5.3% per year over the past 5 years.
Operating margin has contracted, at -0.9% in the latest year.
Free cash flow has grown 12.7% per year over the past 5 years.
Financial health
Total debt has grown in line with revenue (-6.1% vs -5.3% per year).
Operating income covered interest expense -0.2× in the latest year.
Total debt is 24× EBITDA.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$252M
-$19M
72.7%
-0.9%
$47M
$200M
—
2024
$332M
-$588M
73.7%
-174.9%
$12M
$282M
—
2023
$294M
-$56M
67.7%
-9.2%
$2M
$276M
—
2022
$328M
-$311M
70.4%
-56.2%
-$20M
$270M
—
2021
$387M
$46M
73.9%
15.7%
$62M
$271M
—
2020
$331M
-$18M
67.4%
6.8%
$26M
$273M
—
2019
$303M
$100M
67.2%
3.6%
$84M
—
—
2018
$277M
$6M
70.0%
13.3%
$109M
—
—
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$64M
$2M
73.7%
-3.8%
$14M
$173M
—
Dec '25
$115M
-$5M
86.3%
25.5%
$36M
$172M
—
Sep '25
$61M
-$13M
72.6%
-2.9%
$10M
$200M
—
Jun '25
$62M
-$3M
73.7%
-1.5%
$16M
$199M
—
Mar '25
$78M
$22M
77.1%
22.2%
$13M
$258M
—
Dec '24
$51M
-$24M
65.0%
-33.3%
$8M
$256M
—
Sep '24
$55M
-$20M
63.7%
-35.1%
$5M
$282M
—
Jun '24
$71M
-$314M
71.5%
-503.1%
$12M
$280M
—
Mar '24
$68M
-$278M
69.2%
-389.8%
-$801000
$279M
—
Dec '23
$138M
$24M
81.0%
42.3%
-$4M
$277M
—
Sep '23
$81M
-$12M
71.5%
4.8%
$10M
$276M
—
Jun '23
$62M
-$16M
66.0%
-13.8%
-$10M
$279M
—
Mar '23
$68M
-$26M
63.4%
-30.1%
$5M
$277M
—
Dec '22
$84M
-$2M
68.7%
-2.4%
-$3M
$280M
—
Sep '22
$58M
-$230M
58.1%
-394.4%
-$8M
$270M
—
Jun '22
$89M
-$99M
72.8%
17.7%
-$8M
$271M
—
Mar '22
$86M
-$476000
71.8%
7.3%
-$4M
$271M
—
Dec '21
$94M
$19M
74.3%
24.3%
$735000
$271M
—
Sep '21
$98M
$8M
75.4%
11.0%
$19M
$271M
—
Jun '21
$97M
$6M
75.4%
15.4%
$21M
$272M
—
Valuation over time
How the market has priced CRNC against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has fallen from 3.9× (Mar '23) to 1.8× (Jun '26).
Price / sales (P/S)
P/S
Frequently asked questions
Is CRNC growing its revenue and profit?
Over the past 5 years, Cerence Inc.'s revenue has declined 5.3% per year. These are computed facts, not advice.
How much debt does CRNC have?
As of FY2025, Cerence Inc. reported $200M of total debt against — of cash; operating income covered interest expense -0.2×.
What is CRNC's profit margin?
In FY2025, gross margin was 72.7%, operating margin -0.9%, and net margin -7.4%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.